Red Robin Gourmet Burgers Stock News

Red Robin's (RRGB) fiscal first-quarter top line reflects benefits from menu price increases, favorable sales channel mix and growth in restaurant traffic.

Although the revenue and EPS for Red Robin (RRGB) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Stree

Red Robin (RRGB) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of a loss of $0.62 per share. This compares to loss of $0.12 per share a year ago.

Shares of Red Robin Gourmet Burgers Inc. RRGB, +3.51% were up 5.5% after hours on Wednesday after the restaurant chain offered a more upbeat full-year sales forecast and reported a surprise per-share

Red Robin (RRGB) first-quarter fiscal 2023 results are likely to reflect benefits from robust off-premise sales.

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a full-service restaurant chain serving an innovative selection of high-quality gourme

Williams-Sonoma's (WSM) fiscal Q4 performance hurt by soft demand and negative comps.

Although US stocks closed lower on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock

Red Robin (RRGB) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that

Red Robin (RRGB) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. OncoSec Medical Incorpo

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. Reata Pharmaceuticals Inc (NASDAQ: RETA) shares gai

Upgrades According to UBS, the prior rating for Procter & Gamble Co (NYSE:PG) was changed from Neutral to Buy. In the second quarter, Procter & Gamble showed an EPS of $1.59, compared to $1.66 from th

U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 30 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.09% to 32,626.82 while t

Red Robin's (RRGB) fourth-quarter 2022 results hurt by increased labor costs, which get partially offset by increased guest checks.